Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 1;16(1):e51475.
doi: 10.7759/cureus.51475. eCollection 2024 Jan.

Adverse Events of the Long-Term Use of Opioids for Chronic Non-cancer Pain: A Narrative Review

Affiliations
Review

Adverse Events of the Long-Term Use of Opioids for Chronic Non-cancer Pain: A Narrative Review

Abdullh A Altawili et al. Cureus. .

Abstract

Background: The long-term use of opioids for chronic non-cancer pain (CNCP) has drawn more attention and debate. Although opioids are frequently used to treat chronic pain, their effectiveness and safety over extended periods are still unknown.

Objectives: The purpose of this review is to provide an overview of what is currently known about the adverse events of long-term use of opioids in CNCP. It also delivers patient-centered strategies designed to mitigate these risks.

Methods: We conducted a literature search in PubMed, MEDLINE, EMBASE, and Web of Science databases. Search terms included CNCP, pain pathophysiology, opioid pharmacodynamics, opioid prescribing trends, guidelines for opioid use, and opioid side effects. Results: Our review highlights that while opioids may provide short-term relief from CNCP, their effectiveness diminishes over time due to the development of opioid tolerance. This tolerance often leads to increased dosages, which can subsequently result in opioid dependence. Additionally, long-term opioid therapy is associated with a spectrum of adverse effects, including constipation, drowsiness, respiratory depression, and potential for drug interactions. Furthermore, our review indicates that alternative pain management strategies play a crucial role in controlling CNCP. They offer significant benefits with fewer adverse events. These strategies include non-opioid medications, physical therapy, cognitive-behavioral therapy (CBT), various interventional procedures, injection therapy, and acupuncture.

Conclusion: Using opioids to manage CNCP presents several challenges. Given these challenges, alternative treatments are being considered as viable options. Moreover, it is crucial to customize treatment plans to align with the patients' specific health requirements, existing conditions, and potential risks to ensure the best possible outcomes.

Keywords: chronic pain; cncp; long-term; non-cancer; opioids; review.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Overview of pain assessment tools
The tools are based on methodologies referenced in the studies [26-30]. This image was originally provided and edited by the authors.
Figure 2
Figure 2. Step-wise approach of CNCP treatment by the Centers for Disease Control and Prevention
This outline does not consider the specific patient's condition, preferences, or contraindications, which should always be considered when creating a treatment plan. The steps are not always linear and may need to be adjusted based on the patient's response to treatment. The aim is to provide a general idea of how interventions might progress in a typical case of CNCP. Please consult with a healthcare provider for appropriate treatment strategies. This image was originally provided and edited by the authors [2]. CNCP, chronic non-cancer pain
Figure 3
Figure 3. Adverse events associated with long-term use of opioids
This image was originally provided and edited by the authors.

References

    1. Chronic non-cancer pain management and addiction: a review. Genova A, Dix O, Thakur M, Sangha PS. Cureus. 2020;12:0. - PMC - PubMed
    1. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. MMWR Recomm Rep. 2022;71:1–95. - PMC - PubMed
    1. Phenotyping nociceptive, neuropathic, and nociplastic pain: who, how, & why? Nijs J, De Baets L, Hodges P. Braz J Phys Ther. 2023;27:100537. - PMC - PubMed
    1. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. Dahlhamer J, Lucas J, Zelaya C, et al. MMWR Morb Mortal Wkly Rep. 2018;67:1001–1006. - PMC - PubMed
    1. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Yam MF, Loh YC, Tan CS, Khadijah Adam S, Abdul Manan N, Basir R. Int J Mol Sci. 2018;19:2164. - PMC - PubMed

LinkOut - more resources